GERALDINE HENWOOD Insider Trading $BXRX Baudax Bio, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GERALDINE HENWOOD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GERALDINE HENWOOD. GERALDINE HENWOOD is Director in ALKERMES INC ($ALKS) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Chief Executive Officer in Recro Pharma, Inc. ($REPH) and Director in Recro Pharma, Inc. ($REPH) and President and CEO in Recro Pharma, Inc. ($REPH) and President and CEO in Baudax Bio, Inc. ($BXRX).
GERALDINE HENWOOD in Baudax Bio, Inc.
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of GERALDINE HENWOOD: President and CEO
Holdings: 356,307 shares
Latest Transaction: May 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GERALDINE HENWOOD in Baudax Bio, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALKS, BXRX, REPH, TTPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Buy | P | 0.83 | 6,000 | 4,992 | 356,307 | 350.3 K to 356.3 K (+1.71 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 1.14 | 71,283 | 81,263 | 284,872 | 356.2 K to 284.9 K (-20.01 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 1.14 | 11,732 | 13,374 | 356,155 | 367.9 K to 356.2 K (-3.19 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 8.51 | 5,051 | 42,984 | 367,887 | 372.9 K to 367.9 K (-1.35 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Buy | M | 0.00 | 19,070 | 0 | 372,938 | 353.9 K to 372.9 K (+5.39 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Option Exercise | A | 6.33 | 183,673 | 1,162,650 | 183,673 | |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Grant | A | 0.00 | 128,571 | 0 | 353,868 | 225.3 K to 353.9 K (+57.07 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Grant | A | 0.00 | 195,387 | 0 | 225,297 | 29.9 K to 225.3 K (+653.25 %) |
Page: 1